Flagship Pioneering related stories
All articles and analysis
Flagship Ventures expands team with new additionFlagship Ventures has hired Dr. Robert Berendes as a venture partner. Dr. Berendes is a co-owner and partner at a-connect, a Swiss global consulting firm.
- Seventh Sense Biosystems raises $16 mln in Series B funding
Seventh Sense Biosystems, which develops blood collection and diagnostic platforms, has raised $16 million in Series B funding from a group of investors. New investors in the funding were the venture capital arm of Siemens Financial Services, Novartis and Laboratory Corporation of America Holdings. Existing investors Flagship Ventures and Polaris Partners also participated in the funding round.
- Flagship Ventures expands team with new addition
Flagship Ventures said Monday that it has hired Dr. Roger J. Pomerantz as a senior partner. Most recently, Pomerantz served as senior vice president and worldwide head of licensing & acquisitions at Merck & Co.
- Flagship Ventures expands team with new addition
Flagship Ventures said Monday that it has hired Dr. Roger J. Pomerantz as a senior partner. Most recently, Pomerantz served as senior vice president and worldwide head of licensing & acquisitions at Merck & Co.
- VC-backed Editas Medicine hires CEO
Editas Medicine has hired Katrine S. Bosley as CEO. Previously, Bosley worked at Avila Therapeutics where she served as CEO. Based in Cambridge, Mass., Editas Medicine is a transformative genome editing firm. It is backed by Flagship Ventures, Polaris Partners, Third Rock Ventures and Partners Innovation Fund.
- VC-backed Syros Pharmaceuticals hires new CFO
Syros Pharmaceuticals said Tuesday that it has hired Jorge Conde as chief financial officer and chief product officer. Previously, Conde was the co-founder and CFO of Knome. Based in Watertown, Mass., Syros is focused on treating cancer and other diseases. It is backed by Flagship Ventures and ARCH Venture Partners.
- Seres Health pulls in $10 mln Series B
Seres Health said Monday that it has received $10 million in Series B funding. The investors included Flagship Ventures, Enso Ventures, Mayo Clinic and Alexandria Venture Investments. Based in Cambridge, Mass., Seres Health is a clinical stage biotherapeutic company focused on developing drugs that target the human microbiome.
- Flagship leads $12.25 mln round for Pronutria
Pronutria has raised $12.25 million in Series B financing. Flagship Ventures led the round. Based in Cambridge, Mass., Pronutria is a maker of medical foods and nutritional supplements.
- VC-backed Eleven Biotherapeutics raises $50 mln for IPO
Biopharmaceutical company Eleven Biotherapeutics raised $50 million in its IPO after having priced its offering of 5 million shares at $10 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol "EBIO." Citigroup, Cowen and Company and Leerink Partners are the lead underwriters. Its backers include Third Rock Ventures, Flagship Ventures and Jafco.